Dynavax Technologies | Driftskostnader

Operating Expenses Endring Dato
AbbVie USD 9.35B 1.76B 2024-03
Adma Biologics USD 60.05M 25.79M 2024-03
Amgen USD 6.46B 469M 2024-03
AstraZeneca USD 9.56B 1.23B 2024-03
Biogen USD 1.72B 306.9M 2024-03
BioMarin Pharmaceutical USD 570.37M 61.62M 2024-03
Bristol-Myers Squibb USD 10.35B 728M 2024-03
Dynavax Technologies USD 68.56M 4.47M 2024-03
Gilead Sciences USD 6.88B 1.37B 2024-03
Glaxosmithkline GBP 5.87B 1.61B 2024-03
Merck USD 10.02B 6.55B 2024-03
Neurocrine Biosciences USD 410M 52.4M 2024-03
Novartis USD 8.75B 447M 2024-03
Pfizer USD 10.68B 10.12B 2024-03
Regeneron Pharmaceuticals USD 2.39B 74.9M 2024-03
Roche Holding CHF 20.02B 5.04B 2023-06
Sarepta Therapeutics USD 378.56M 1.6M 2024-03
TG Therapeutics USD 72.74M 16.29M 2024-03
Vertex Pharmaceuticals USD 1.47B 29M 2024-03



Dynavax Technologies Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.